The epistasis between vascular homeostasis genes is apparent in essential hypertension

Atherosclerosis

Volumn 220, Issue 2, 2012, Pages 418-424

  Kumar, Rahul ^a,c   Nejatizadeh, Azim ^a   Gupta, Mohit ^b   Markan, Amandeep ^b   Tyagi, Sanjay ^b   Jain, S K ^c   Pasha, M A Qadar ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b G B PANT HOSPITAL   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Association study; Epistasis; Haplotype; Hypertension; Polymorphism; Vascular homeostasis

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRATE; NITRITE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPISTASIS; ESSENTIAL HYPERTENSION; ETHNICITY; FEMALE; GENE INTERACTION; GENOTYPE; HAPLOTYPE; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALDOSTERONE; ALDOSTERONE SYNTHASE; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; INDIA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84855981704     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.036     Document Type: Article

References (30)

1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
2. Whitworth J.A. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003, 21:1983-1992.
3. Lifton R.P., Gharavi A.G., Geller D.S. Molecular mechanisms of human hypertension. Cell 2001, 104:545-556.
4. Vasan R.S., Larson M.G., Leip E.P., Evans J.C., O'Donnell C.J., Kannel W.B., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001, 345:1291-1297.
5. Hizawa N., Maeda Y., Konno S., Fukui Y., Takahashi D., Nishimura M. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility. Clin Exp Allergy 2006, 36:872-876.
6. Misono M., Maeda S., Iemitsu M., Nakata Y., Otsuki T., Sugawara J., et al. Combination of polymorphisms in the beta2-adrenergic receptor and nitric oxide synthase 3 genes increases the risk for hypertension. J Hypertens 2009, 27:1377-1383.
7. Yang M., Choi Y., Hwangbo B., Lee J.S. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer 2007, 57:135-142.
8. Laurila P.P., Naukkarinen J., Kristiansson K., Ripatti S., Kauttu T., Silander K., et al. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis. Arterioscler Thromb Vasc Biol 2010, 30:346-352.
9. Williams S.M., Addy J.H., Phillips J.A., Dai M., Kpodonu J., Afful J., et al. Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000, 36:2-6.
10. Verdecchia P., Angeli F., Cavallini C., Gattobigio R., Gentile G., Staessen J.A., et al. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Eur Heart J 2009, 30:679-688.
11. Luft F.C. Renin-angiotensin system-related highlights from the High Blood Pressure Research Conference annual meeting. J Renin Angiotensin Aldosterone Syst 2008, 9:242-247.
12. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
13. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
14. Hahn L.W., Ritchie M.D., Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003, 19:376-382.
15. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
16. Kumar R., Nejatizadeh A., Arif E., Akhtar S., Gupta M., Tyagi S., et al. Multi-locus interactions of vascular homeostasis genes in essential hypertension: a gender-based study. Clin Chim Acta 2009, 405:87-93.
17. Nejatizadeh A., Kumar R., Stobdan T., Goyal A.K., Sikdar S., Gupta M., et al. Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension. Free Radic Biol Med 2008, 44:1912-1918.
18. Nejatizadeh A., Kumar R., Stobdan T., Goyal A.K., Gupta M., Tyagi S., et al. CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension. Clin Biochem 2010, 43:136-141.
19. Dordelmann C., Telgmann R., Brand E., Hagedorn C., Schroer B., Hasenkamp S., et al. Functional and structural profiling of the human thrombopoietin gene promoter. J Biol Chem 2008, 283:24382-24391.
20. Hagedorn C., Telgmann R., Dordelmann C., Schmitz B., Hasenkamp S., Cambien F., et al. Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoter. Arterioscler Thromb Vasc Biol 2009, 29:1638-1643.
21. Jeunemaitre X., Inoue I., Williams C., Charru A., Tichet J., Powers M., et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997, 60:1448-1460.
22. Staessen J.A., Wang J.G., Brand E., Barlassina C., Birkenhager W.H., Herrmann S.M., et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001, 19:1349-1358.
23. Ye S., Dhillon S., Seear R., Dunleavey L., Day L.B., Bannister W., et al. Epistatic interaction between variations in the angiotensin I converting enzyme and angiotensin II type 1 receptor genes in relation to extent of coronary atherosclerosis. Heart 2003, 89:1195-1199.
24. Bell J.T., Wallace C., Dobson R., Wiltshire S., Mein C., Pembroke J., et al. Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension. Hum Mol Genet 2006, 15:1365-1374.
25. Zhao Q., Wang L., Yang W., Chen S., Huang J., Fan Z., et al. Interactions among genetic variants from contractile pathway of vascular smooth muscle cell in essential hypertension susceptibility of Chinese Han population. Pharmacogenet Genomics 2008, 18:459-466.
26. Koenig W. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis. Ann Med 2009, 41:332-343.
27. Ken-Dror G., Talmud P.J., Humphries S.E., Drenos F. APOE/C1/C4/C2 gene cluster genotypes, haplotypes and lipid levels in prospective coronary heart disease risk among UK healthy men. Mol Med 2010, 16:389-399.
28. Teslovich T.M., Musunuru K., Smith A.V., Edmondson A.C., Stylianou I.M., Koseki M., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
29. Reilly M.P., Li M., He J., Ferguson J.F., Stylianou I.M., Mehta N.N., et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011, 377(January):383-392.
30. Fox E.R., Young J.H., Li Y., Dreisbach A.W., Keating B.J., Musani S.K., et al. Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet 2011, 20:2273-2284.